The Study of Prognosis in Nonsmall Cell Lung Cancer by the Expression of Multiple Oncogenes

傅小龙,蒋国粱,朱雄增,施达仁,许良中,赵森

DOI: https://doi.org/10.3781/j.issn.1000-7431.2002.02.018

2002-01-01

Tumori

Abstract:Objective To predict the prognosis of non-small cell lung cancer by measuring multiple oncoprotein expression. Methods From 1981 to 1994, 158 patients with non-small cell lung cancer entered this study. The protein expression of pan-ras, c-myc, c-erb B2, EGFR and p 53 were measured by immunohitochemistry assay. The rates of survival, local control and distant metastasis were estimated by Kaplan-Meier method with Log-rank test to compare the difference among subgroups. Cox model was used for multivariate analyses. Results The overall five year actuarial survival?local control and distant metastasis rates were 44%,63% and 40%,respectively. Univariate analysis showed that the patients with either pan-ras or p 53 protein expression developed more distant metastases than those with negative ( P =0.039,0.06). However, there were no significant differences in survival?local control and distant metastasis by Cox analyses for each oncogene protein expression. The prediction had been improved by using the sum of positive oncoprotein stains. Especially, when all patients were divided into six sub groups according to the protein expression statues , there was a significant trend. As the sum of positive stains was risen distant metastasis rate was increasing in distant metastasis among groups. Conclusion 1. It would be more accurate to predict the prognosis of NSCLC by comprehensive multi oncogenes study than single oncogene study. 2. Oncoprotein expression could predict the potential of the distant metastases, not the local control.